J Am Pharm Assoc (2003). 2013 Sep-Oct;53(5):505-12. doi: 10.1331/JAPhA.2013.13008.
To compare the completeness of medication and blood pressure monitoring among patients requesting medication refills through the pharmacist-managed medication refill and laboratory monitoring program (MRLMP) versus usual care.
Quasiexperimental study.
Kaiser Permanente Colorado between November 2011 and June 2012.
Patients requesting chronic medication prescription refills.
Community pharmacists managed the refill authorization request (RAR) process at the intervention site. For each RAR, the pharmacist reviewed patient medication monitoring needs and ordered laboratory test(s) or a clinic visit, as needed, before approval.
For medications due for laboratory or blood pressure monitoring at the time of the RAR, the 1-month rate of attaining complete monitoring was compared between groups. Pharmacist, primary care physician (PCP), and patient satisfaction and PCP time saved also were compared.
3,797 RARs for MRLMP-eligible medications were approved in the month following MRLMP implementation in the intervention and control clinics. The intervention and control groups converted 49% and 29% of medications due for laboratory monitoring ( P < 0.001) and 56% and 33% of those due for blood pressure monitoring, respectively ( P = 0.020). The intervention group PCPs were more likely than control group PCPs to report being "very satisfied" with the RAR process (80% vs. 27%, P = 0.015) and spent fewer minutes per day on refill requests (mean 17 vs. 23, P = 0.049). The intervention group pharmacists reported higher job satisfaction (mean index score 22 vs. 18, P = 0.024), and intervention group patients reported higher satisfaction with the "readiness" of their prescription when they came to pick it up (91% vs. 80%, P = 0.004).
A pharmacist-managed MRLMP resulted in improved process-related outcomes. Future studies should assess clinical outcomes.
比较通过药剂师管理的药物续药和实验室监测计划(MRLMP)与常规护理的患者在药物监测方面的完整性。
准实验研究。
2011 年 11 月至 2012 年 6 月期间科罗拉多州的 Kaiser Permanente。
要求长期药物处方续药的患者。
社区药剂师在干预点管理续药授权请求(RAR)流程。对于每个 RAR,药剂师审查患者的药物监测需求,并在批准前根据需要安排实验室检查或诊所就诊。
对于 RAR 时需要进行实验室或血压监测的药物,比较两组在 1 个月内达到完全监测的比例。还比较了药剂师、初级保健医生(PCP)和患者满意度以及 PCP 节省的时间。
在 MRLMP 实施后的一个月内,干预和对照组的 MRLMP 合格药物的 RAR 分别有 3797 个得到批准。干预组和对照组中,实验室监测药物的转化率分别为 49%和 29%(P<0.001),血压监测药物的转化率分别为 56%和 33%(P=0.020)。干预组的 PCP 比对照组的 PCP 更有可能报告对 RAR 过程“非常满意”(80%比 27%,P=0.015),并且每天在药物续方请求上花费的时间更少(平均 17 分钟比 23 分钟,P=0.049)。干预组药剂师报告的工作满意度更高(平均指数得分 22 比 18,P=0.024),干预组患者在取药时报告他们的处方“准备就绪”的满意度更高(91%比 80%,P=0.004)。
药剂师管理的 MRLMP 导致了与过程相关的结果的改善。未来的研究应该评估临床结果。